These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31376036)

  • 1. Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy.
    Li XD; Huang CW; Liu ZF; Jiang LJ; Chen JW; Xie D; Zhou FJ; Lu HM; Liu ZW
    Ann Surg Oncol; 2019 Nov; 26(12):4148-4156. PubMed ID: 31376036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
    Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W
    PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
    Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
    World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
    Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
    Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.
    Debatin NF; Bady E; Mandelkow T; Huang Z; Lurati MCJ; Raedler JB; Müller JH; Vettorazzi E; Plage H; Samtleben H; Klatte T; Hofbauer S; Elezkurtaj S; Furlano K; Weinberger S; Giacomo Bruch P; Horst D; Roßner F; Schallenberg S; Marx AH; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke TH; Hallmann S; Koch S; Adamini N; Lennartz M; Minner S; Simon R; Sauter G; Zecha H; Schlomm T; Blessin NC
    Eur Urol; 2024 Jul; 86(1):42-51. PubMed ID: 38383257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2016 Jan; 23(1):335-42. PubMed ID: 26152275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer.
    Rejeb SB; Elfekih S; Kouki N; Boulma R; Khouni H
    J Egypt Natl Canc Inst; 2024 Mar; 36(1):9. PubMed ID: 38523233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
    Donnem T; Hald SM; Paulsen EE; Richardsen E; Al-Saad S; Kilvaer TK; Brustugun OT; Helland A; Lund-Iversen M; Poehl M; Olsen KE; Ditzel HJ; Hansen O; Al-Shibli K; Kiselev Y; Sandanger TM; Andersen S; Pezzella F; Bremnes RM; Busund LT
    Clin Cancer Res; 2015 Jun; 21(11):2635-43. PubMed ID: 25680376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
    Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Li XD; Chen SL; Dong P; Chen JW; Wang FW; Guo SJ; Jiang LJ; Zhou FJ; Xie D; Liu ZW
    Sci Rep; 2016 Feb; 6():20894. PubMed ID: 26869491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
    Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
    Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.